Can chatbots help with genetic testing for cancer risk?
A study from Huntsman Cancer Institute at the University of Utah (the U) and NYU…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
ESMO 2024: Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359),…
Genes with strong impact on menopause timing also link to cancer risk
New research has found four genes with some of the largest known effects on the…
ESMO 2024: Long-course radiotherapy is better than short-course for organ preservation in rectal cancer
The COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given…
Gut bacteria influence responses to immunotherapy in patients with asbestos related cancer
A cancer study has found that certain gut bacteria may influence whether or not a…
Researchers develop nanostructures to improve immune response to cancer
Immune checkpoint blockade (ICB) is one of the primary methods of tumour immunotherapy. It involves reactivating…
TGF-beta and RAS signaling are both required for lung cancer metastasis, study finds
When it comes to cancer metastasis, it takes two to tango. That was one of…
Breaking the trend: Skin cancer incidence in young adults declines
The risk of skin cancer, malignant melanoma, now appears to be decreasing in Sweden -…
Researchers identify factor that drives prostate cancer-causing genes
Researchers at the University of Michigan Health Rogel Cancer Center, USA, have uncovered a key…
WCLC 2024: NeoCOAST-2 Data shows combination of Durvalumab with novel agents increases pathological responses in resectable NSCLC — Data builds on AEGEAN study research
Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd…